ArticleMedicina (Kaunas, Lithuania)2022

Short-Term Effects of Brolucizumab in the Treatment of Wet Age-Related Macular Degeneration or Polypoidal Choroidopathy Refractory to Previous Anti-Vascular Endothelial Growth Factor Therapy.

Alan Y Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.